Kairos Pharma KAPA
NYSE KAPA
$0.54 -0.03 (-5.76%)
As of: Oct 22, 2026 · 3:50 PM EDT

Kairos Pharma (KAPA) Cash from Financing Activities (2023 - 2025)

Updated

Kairos Pharma (KAPA) recorded Cash from Financing Activities of $6.66 million in FY2025, up 29.7% from $5.13 million in FY2024.

Analysis

Kairos Pharma (KAPA) Cash from Financing Activities (2023 - 2025) Analysis & Trends

  • Per Business Quant data, KAPA's Cash from Financing Activities was $5.13 million in FY2024 and -$425,000 in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 8.43 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn -8.53 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn -5.05 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 1.76 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn -2.02 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn -3.89 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn -1.48 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 2.34 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn -3.66 Bn
10 Kairos Pharma 10.01 Mn -2.40 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 223,000.00
Mar 31, 2025 3.06 Mn
Dec 31, 2024 -142,000.00
Sep 30, 2024 5.22 Mn
Jun 30, 2024 149,000.00
Mar 31, 2024 -89,000.00
Dec 31, 2023 -72,000.00
API Access

Kairos Pharma Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=KAPA&period=max&api_key=YOUR_API_KEY